Charles G. Drake MD / PhD, Director GU Medical Oncology, Co-Director Immunotherapy Program, Associate Director for Clinical Research, Herbert Irving Cancer Center at Columbia University presents To Combine or Sequence: Biological Rationale at the 2016 annual International Kidney Cancer Symposium.
To Combine or Sequence: Biological Rationale
